CME

CME


Latest Episodes

First-Line Treatment of Metastatic Melanoma After Adjuvant Anti-PD-1
April 26, 2024

Host: Allison Betof Warner, MD, PhD This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma who can benefit from LAG-3/PD-1 co

Idiopathic Pulmonary Fibrosis: The Role of Radiology in Accurate and Timely Diagnosis
April 25, 2024

Host: Jonathan Chung, MD Host: Seth Kligerman, MD Learn from experts about differentiating idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases and the role of radiology in effectively diagnosing IPF with a multidiscipli

Experts on the Ground: Data Updates on Emerging Therapies for IgAN
April 25, 2024

Host: Richard Lafayette, MD, FACP Expert Nephrologist Richard Lafayette, MD, FACP, gives an overview of top abstracts from Kidney Week 2023 and updates on emerging therapies for IgAN.

Experts on Call: Connecting Specialists and PCPs to Improve Patient-Centered Obesity Management
April 25, 2024

Host: Robert F. Kushner, MD Host: Donna Ryan, MD Host: Christopher D. Still, DO, FACN, FACP, FTOS Obesity experts review obesity management strategies and provide insight on best practices for implementation in a primary care setting.

Managing Indolent Systemic Mastocytosis: A Multidisciplinary Case Review
April 24, 2024

Host: Cem Akin, MD, PhD Guest: Daniel J. DeAngelo, MD, PhD New tyrosine kinase inhibitor (TKI) treatment options can significantly reduce symptom burden in patients with moderate to severe indolent systemic mastocytosis (ISM). Studies report

Multidisciplinary Approach to Diagnosing and Managing Indolent Systemic Mastocytosis: The Changing Landscape
April 24, 2024

Host: Cem Akin, MD, PhD Guest: Daniel J. DeAngelo, MD, PhD Guest: Matthew J. Hamilton, MD Patients with indolent systemic mastocytosis frequently report a symptom burden disproportionate to measurable disease burden. Anti-mediator interv

The Multiple Faces of ATTRv-PN
April 23, 2024

Guest: Sami Khella, MD Guest: Marcia Waddington-Cruz, MD, PhD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectu

ATTRv-PN: A Complicated Disease With a Poor Prognosis
April 23, 2024

Guest: John Berk, MD Guest: Sami Khella, MD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interview

Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?
April 23, 2024

Guest: Sami Khella, MD Guest: Marcia Waddington-Cruz, MD, PhD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectu

ATTR Amyloidosis: Familial Vs Wild-Type
April 23, 2024

Guest: Noel Dasgupta, MD, FACC Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the co